A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives

HIV Clinical Trial

— P&T  

Official title:

A Comprehensive Approach to Secondary HIV Prevention and Care Among Positives

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01935440
• Other study ID #: R01DA032217
• Secondary ID: R01DA032217
• Status: Completed
• Phase: N/A
• Start date: November 1, 2012
• Est. completion date: January 31, 2017

Study information

• Verified date: July 2018
• Source: Johns Hopkins Bloomberg School of Public Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this study is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators.

Description:

The primary objective of this funded research is to conduct an HIV prevention intervention to train HIV seropositive drug users to be peer health educators to: (1) recruit their high risk social network members for voluntary HIV counseling and testing (VCT) at the research clinic, (2) promote risk reduction among social network members, and (3) promote engagement in HIV care by encouraging HIV seropositive network members to schedule and keep HIV primary care appointments. There will be four types of participants in the Full Trial: 1) Index, 2) Testing Network 3) Longitudinal Network and 4) HIV positive network participants. This longitudinal study includes baseline, 6-months, and 12-month assessments

Recruitment information / eligibility

• Status: Completed
• Enrollment: 632
• Est. completion date: January 31, 2017
• Est. primary completion date: January 31, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Index

1. 18 years old or older

2. documentation of HIV positive status

3. report one of following risk behaviors in past 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Testing network

1. 18 or older

2. provided testing coupon provided by an index participant

Longitudinal network participant-

1. tested HIV negative at the Lighthouse via redeeming a testing coupon

2. reported interacting with index who gave the coupon at least weekly

3. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Positive Networks

1. HIV positive

2. report one of following risk behaviors in the prior 90 days: sharing injection equipment, use of crack cocaine, or unprotected vaginal or anal sex

Exclusion Criteria:

Index- already enrolled in the study as a Network participant

Testing network- already enrolled in the study as a Network participant

Longitudinal network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Positive network- a) already enrolled in the study as a Network participant b) already enrolled in the study as a Index participant

Related Conditions & MeSH terms

• HIV

Intervention

Behavioral:
• Prevention & Testing
6 group sessions, 1 individual session, and 1 dyad session
• Prevention & Testing Control
7 group sessions

Locations

Country	Name	City	State
United States	Lighhouse Studies @ Peer Point	Baltimore	Maryland

Sponsors (2)

Lead Sponsor	Collaborator
Johns Hopkins Bloomberg School of Public Health	National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	change in HIV medication adherence		6 month
Primary	change in frequency in attending HIV medical appointments		6 month
Secondary	change in sharing injection equipment		6 month
Secondary	change in condom use		6 month